Jennifer Lew


Ms. Lew joined Annexon Biosciences as Chief Financial Officer in June 2019. She previously served as Chief Financial Officer for Aduro Biotech, Inc. While at Aduro, Ms. Lew played a leadership role in the company‚Äôs preparation and execution of its initial public offering and provided financial and strategic oversight in areas of fundraising, investor relations, strategic planning and board governance. Prior to Aduro, Ms. Lew held various roles at Dynavax Technologies Corporation from 2004 to October 2013, most recently as Vice President of Finance and Principal Accounting Officer, where she was responsible for finance and accounting operations. Before joining Dynavax, Ms. Lew held positions as Assistant Controller and Director of Finance at QRS Corporation, a publicly-held technology company, from 2000 to 2004. Ms. Lew began her career in the audit practice at Ernst & Young from 1994 to 1999. She earned a B.A. in Economics/Accounting and Government from Claremont McKenna College and is a Certified Public Accountant (inactive status).